Published in Medicine and Law Weekly, May 4th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Hollis-Eden Pharmaceuticals.
Report 1: Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced financial results for the fourth quarter and year ended December 31, 2006. In addition, the Company is providing a summary of feedback from a recent face-to-face meeting with the Department of Health and Human Services (HHS) regarding NEUMUNE(R) (HE2100) for the treatment of acute radiation syndrome (ARS), as well as a review of the status of NEUMUNE and its other development...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly